Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) that require piperazine-based structures. Its protected piperazine ring allows for selective reactions at other functional sites, making it valuable in multi-step organic syntheses. Commonly employed in medicinal chemistry for constructing drug candidates targeting neurological disorders, infections, and metabolic diseases. The ester groups enable further derivatization, facilitating the creation of diverse molecular architectures. Suitable for use in research settings for building complex molecules with enhanced bioavailability and target specificity.